Home/Filings/4/0001294002-05-000012
4//SEC Filing

THEOFAN GEORGIA 4

Accession 0001294002-05-000012

CIK 0000817785other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 7:34 PM ET

Size

4.8 KB

Accession

0001294002-05-000012

Insider Transaction Report

Form 4
Period: 2005-03-31
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2005-03-31$0.78/sh+3,926$3,06218,855 total
Footnotes (1)
  • [F1]Matching company contribution to 401K account.

Issuer

IMMUNE RESPONSE CORP

CIK 0000817785

Entity typeother

Related Parties

1
  • filerCIK 0001280158

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 7:34 PM ET
Size
4.8 KB